# Canbex Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/canbex-therapeutics

- Industry: Pharmaceuticals
- Headquarters: London, UK
- Website: www.canbex.co.uk
- Total disclosed funding: $6.5M
- Latest round: Series A (Apr 11, 2013)
- Investors on record: 5

## About

Canbex Therapeutics Ltd is dedicated to the development of novel compounds for the treatment of spasticity in multiple sclerosis (MS) and potentially other disorders.

## Funding rounds

- Series A, Apr 11, 2013, $5.9M — Wellcome Trust, M Ventures, UCL Business plc
- Seed, Jan 1, 2006, $0.6M — Bloomsbury Bioseed Fund, Esperante Ventures

## Investors

- Bloomsbury Bioseed Fund (https://capitalatlas.ai/funds/bloomsbury-bioseed-fund) — Seed
- Esperante Ventures (https://capitalatlas.ai/funds/esperante-ventures) — Seed
- Wellcome Trust — Series A
- M Ventures (https://capitalatlas.ai/funds/m-ventures) — Series A
- UCL Business plc — Series A